A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Genzada Pharmaceuticals USA, Inc.
SpeciCare
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)